Method for preparing single cell suspension of nerve tissues
Patent Information
- Application Number
- PCT/CN2024/074357
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2024-01-29
- Publication Date
- 2024-11-21
AI Technical Summary
When preparing single-cell suspensions of nervous tissue using existing technology, cell viability fluctuates, purity and yield are low, and mechanical and enzymatic digestion methods are difficult to effectively separate mononuclear cells in the central nervous system, affecting the quality of flow cytometry analysis.
Using a method that combines mechanical and enzymatic methods, the neural tissue is enzymatically hydrolyzed and Percoll discontinuous density gradient centrifugation is used to separate mononuclear cells through hydrolytic enzyme solution and Percoll gradient centrifugation. Enzyme incubation conditions and centrifugation parameters are optimized to reduce cell damage. and clumping phenomena.
It improves the cell survival rate and purity of the single cell suspension of neural tissue, provides a highly active and high-purity cell sample, is suitable for flow cytometry analysis, and is simple to operate and low in cost.
Smart Images

Figure CN2024074357_21112024_PF_FP_ABST
Abstract
Description
A method for preparing a single cell suspension of neural tissue Technical Field
[0001] The invention belongs to the technical field of biomedicine, and particularly relates to a method for preparing a nerve tissue single cell suspension. Background Art
[0002] Preparation of single-cell tissue suspensions is a fundamental skill in cell biology. Dissociated single cells are required in various areas of neuroscience research, including developmental studies, disease pathophysiology, drug and toxin screening, and transplantation of animal models of neurological diseases. The use of single-cell analysis techniques, such as flow cytometry, to study biological processes mediated by interactions between heterogeneous cell populations has greatly advanced neuroscience research. These techniques rely on the preparation of single-cell tissue suspensions. However, the close association of neuronal cell bodies with thousands of synapses and the fragility of axons and dendrites hinder the acquisition of single cells from neural tissue. Improper tissue dissociation can reduce the quality of data obtained in cell function and molecular experiments, resulting in experimental artifacts.
[0003] At present, the preparation methods of single cell suspension of solid tissue include mechanical method and enzymatic digestion method. Mechanical method includes grinding method, shearing method, homogenization method, etc. Mainly by applying greater pressure to the tissue, cells are released from the tissue. However, manual mechanical dissociation of tissue causes fluctuations in the yield of viable cells due to differences in pipetting amplitude and speed, and has poor reproducibility. Enzymatic digestion method mainly hydrolyzes the collagen fibers and mucopolysaccharides between tissues, separates the tight junctions between cells, and achieves the purpose of preparing single cell suspension. However, the enzyme incubation conditions are more difficult to control, and solid tissue cells tend to adhere to form a mass, resulting in a low yield. In addition, due to the wide variety of cell types in the central nervous system (CNS) and the low proportion of lymphocytes, the cell purity, activity and yield obtained by these two methods are all low, which is not conducive to technical analysis such as flow cytometry.
[0004] Summary of the Invention
[0005] The purpose of the present invention is to make up for the deficiencies of the prior art and provide a method for preparing a single cell suspension of neural tissue, which can efficiently obtain mononuclear cells from neural tissue with high cell survival rate, high purity and good cell activity.
[0006] To achieve the above object, the present invention provides a method for preparing a single-cell suspension of neural tissue, comprising the following steps:
[0007] (1) enzymatically hydrolyzing the neural tissue fragments with a hydrolytic enzyme solution, collecting the precipitate by centrifugation, and resuspending the fragments; the hydrolytic enzyme solution includes a trypsin solution or a papain solution, and the size of the fragments is less than 1 mm × 1 mm × 1 mm; the neural tissue includes brain tissue or spinal cord tissue;
[0008] (2) filtering the resuspension obtained in step (1), centrifuging, and resuspending the precipitate in 30% Percoll working solution;
[0009] (3) adding the resuspension obtained in step (2) to the top of 70% Percoll working solution, centrifuging, and collecting the white blood cell layer;
[0010] (4) mixing the white blood cell layer obtained in step (3) with 1× Hank's balanced salt solution containing 2% v / v fetal bovine serum, centrifuging, collecting the precipitate and resuspending it to obtain the neural tissue single cell suspension;
[0011] The 30% Percoll working solution is prepared by mixing 100% Percoll working solution and 1× Hank's balanced salt solution in a volume ratio of 3:7;
[0012] The 70% Percoll working solution is prepared by mixing 100% Percoll working solution and 1× Hank's balanced salt solution in a volume ratio of 7:3;
[0013] The 100% Percoll working solution is prepared by mixing the Percoll stock solution and 10×PBS in a volume ratio of 9:1; the 10×PBS is free of Ca 2+ and Mg 2+ , containing 0.5mmol / L EDTA.
[0014] Preferably, the enzymatic hydrolysis temperature is 55° C., the pH is 6.0, and the time is 30 min.
[0015] Preferably, the concentration of the enzyme in the hydrolase solution is 20 mg / mL.
[0016] Preferably, the centrifugal speed in step (1) is 2000 r / min and the time is 5 min.
[0017] Preferably, the filtration in step (2) uses a cell sieve with a pore size of 70 μm.
[0018] Preferably, the centrifugation temperature in step (2) is 4° C., the rotation speed is 2000 r / min, and the time is 15 min.
[0019] Preferably, the volume ratio of the resuspension in step (3) to the 70% Percoll working solution is 10:3.
[0020] Preferably, the centrifugation temperature in step (3) is 4° C., the rotation speed is 2000 r / min, the time is 15 min, the acceleration is set to 3, and the deceleration is set to 2.
[0021] Preferably, the centrifugation temperature in step (4) is 4° C., the rotation speed is 2000 r / min, and the time is 5 min.
[0022] Preferably, the resuspension in step (4) uses 1× Hank's balanced salt solution containing 2% v / v fetal bovine serum. Beneficial effects:
[0023] This method combines mechanical and enzymatic methods to process neural tissue, using Percoll discontinuous density gradient centrifugation to isolate mononuclear cells from neural tissue, providing a highly active and pure cell sample for flow cytometry analysis. Evaluation of cell viability using trypan blue staining and flow cytometry demonstrated a high survival rate for the cells extracted using this method, and the isolation process did not affect cell viability or alter the expression of intracellular or extracellular marker proteins.
[0024] Furthermore, the present invention determines the optimal centrifugal speed, acceleration, number of cycles, and enzyme incubation temperature conditions based on the specific characteristics of neural tissue, and uses a cell screen with a 70 μm pore size to filter the enzymatically hydrolyzed tissue, thereby reducing cell damage and effectively avoiding cell clumping. The operation is simple, rapid, and low-cost, and can be completed using common experimental equipment. It is crucial for studying the functions of mononuclear cells (including neurons, glial cells, infiltrating lymphocytes, etc.) in the CNS. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments are briefly introduced below.
[0026] FIG1 is a comparison of cell viability in brain tissue single cell suspensions prepared by different methods;
[0027] Figure 2 is a graph showing the percentage of mononuclear cells in brain tissue prepared by different methods detected by flow cytometry; among them, mechanical refers to the grinding and homogenization method of comparative example 1, enzymatic refers to the papain hydrolysis method of comparative example 2, and mechanical+enzymatic refers to the technical method of the present invention. DETAILED DESCRIPTION
[0028] The present invention provides a method for preparing a single-cell suspension of neural tissue, comprising the following steps:
[0029] (1) enzymatically hydrolyzing the neural tissue fragments with a hydrolytic enzyme solution, collecting the precipitate by centrifugation, and resuspending the fragments; the hydrolytic enzyme solution includes a trypsin solution or a papain solution, and the size of the fragments is less than 1 mm × 1 mm × 1 mm; the neural tissue includes brain tissue or spinal cord tissue;
[0030] (2) filtering the resuspension obtained in step (1), centrifuging, and resuspending the precipitate in 30% Percoll working solution;
[0031] (3) adding the resuspension obtained in step (2) to the top of 70% Percoll working solution, centrifuging, and collecting the white blood cell layer;
[0032] (4) mixing the white blood cell layer obtained in step (3) with 1× Hank's balanced salt solution containing 2% v / v fetal bovine serum, centrifuging, collecting the precipitate and resuspending it to obtain the neural tissue single cell suspension;
[0033] The 30% Percoll working solution is prepared by mixing 100% Percoll working solution and 1× Hank's balanced salt solution in a volume ratio of 3:7;
[0034] The 70% Percoll working solution is prepared by mixing 100% Percoll working solution and 1× Hank's balanced salt solution in a volume ratio of 7:3;
[0035] The 100% Percoll working solution is prepared by mixing the Percoll stock solution and 10×PBS in a volume ratio of 9:1; the 10×PBS is free of Ca 2+ and Mg 2+ , containing 0.5mmol / L EDTA.
[0036] In the present invention, the neural tissue is preferably cut into pieces less than 1 mm x 1 mm x 1 mm to obtain tissue fragments. In the present invention, the neural tissue preferably comprises brain tissue or spinal cord tissue, more preferably brain tissue. In the present invention, the neural tissue is preferably wetted with 1× Hank's balanced salt solution before cutting.
[0037] After obtaining the tissue fragments, the present invention performs enzymatic hydrolysis on the tissue fragments, collects the precipitate by centrifugation, and resuspends the tissue fragments to obtain a first resuspension. In the present invention, the hydrolase solution preferably comprises a trypsin solution or a papain solution, more preferably a papain solution. The enzymatic hydrolysis temperature of the present invention is preferably 55°C, the pH is preferably 6.0, and the time is preferably 30 minutes. The enzyme concentration in the hydrolase solution is preferably 20 mg / mL.
[0038] In the present invention, the centrifugal speed is preferably 2000 r / min, and the time is preferably 5 min. The filtration in the present invention preferably uses a cell sieve with a pore size of 70 μm.
[0039] After obtaining the first resuspension, the present invention filters the first resuspension, centrifuges, obtains a precipitate, and resuspends it in 30% Percoll working solution to obtain a second resuspension. In the present invention, the centrifugation temperature is preferably 4°C, the speed is preferably 2000 r / min, and the time is preferably 15 min.
[0040] After obtaining the second resuspension, the present invention adds the obtained second resuspension to the top of the 70% Percoll working solution, centrifuges, and collects the white blood cell layer. In the present invention, the centrifugation temperature is preferably 4°C, the speed is preferably 2000 rpm, the time is preferably 15 minutes, the acceleration is preferably set to 3, and the deceleration is preferably set to 2. The volume ratio of the resuspension to the 70% Percoll working solution is preferably 10:3.
[0041] After obtaining the buffy coat, the buffy coat is mixed with 1× Hank's balanced salt solution containing 2% v / v fetal bovine serum, centrifuged, and the precipitate is collected and resuspended to obtain the neural tissue single cell suspension. In the present invention, the centrifugation temperature is preferably 4°C, the speed is preferably 2000 rpm, and the time is preferably 5 minutes. The resuspension is preferably performed in 1× Hank's balanced salt solution containing 2% v / v fetal bovine serum.
[0042] The present invention has a high survival rate of mononuclear cells in the neural tissue single-cell suspension obtained by the above method, and the separation process does not affect the cell activity and does not change its intracellular and extracellular marker proteins. It can be further subjected to cell culture, flow cytometric analysis, and protein and nucleic acid analysis. Combining these analytical techniques, quantitative analysis of multiple parameters of single cells can be achieved.
[0043] To further illustrate the present invention, a method for preparing a single-cell suspension of neural tissue provided by the present invention is described in detail below with reference to the accompanying drawings and examples, but they should not be construed as limiting the scope of protection of the present invention.
[0044] Example 1
[0045] 1. Place fresh neural tissue (rat / mouse brain or spinal cord) in a 10 cm jar of culture medium and add 1 mL of Hank's balanced salt solution (1× HBSS) to keep the brain moist. Use a scalpel blade to mince the brain into pieces smaller than 1 mm x 1 mm x 1 mm.
[0046] 2. Transfer the brain tissue fragments to a tissue dissociation tube. Select papain and dissolve it in PBS to a concentration of 20 mg / mL. Add 2 mL of enzyme working solution to the dissociation tube.
[0047] 3. Adjust the pH value of the dissociation tube mixture containing the enzyme working solution to 6.0, place it in a water bath, adjust the temperature to 55°C, and water bath for 30 minutes.
[0048] 4. After the water bath, centrifuge at an acceleration of 1500 r / min and a speed of 2000 r / min for 5 minutes.
[0049] 5. After centrifugation, resuspend the sample, filter it through a 70 μm pore size cell sieve, and collect the cell filtrate into a 50 mL centrifuge tube.
[0050] 6. Isolate mononuclear cells from the CNS using the Percoll gradient separation method. The specific steps are as follows:
[0051] (1) First, mix the Percoll stock solution with 10×PBS (without Ca 2+ and Mg 2+ , containing 0.5 mmol / L EDTA) were mixed at a volume ratio of 9:1 to prepare 100% Percoll working solution for the experiment;
[0052] (2) Prepare 70% Percoll working solution by mixing 100% Percoll working solution with 1× HBSS at a volume ratio of 7:3.
[0053] (3) Centrifuge the cell filtrate in the 50 mL centrifuge tube at 4°C, 2000 rpm for 15 min. Resuspend the cells in 7 mL of 1× HBSS, then add 3 mL of 100% Percoll working solution and mix thoroughly by pipetting to obtain 30% Percoll working solution.
[0054] (4) First, add 3 mL of 70% Percoll working solution to a 15 mL centrifuge tube. Then, use a 1 mL pipette to slowly add the 30% Percoll working solution onto the 70% Percoll working solution. Then, use a swing-out centrifuge at 4°C, 2000 rpm, acceleration setting 3, deceleration setting 2, and centrifuge for 25 minutes. After centrifugation, a white cell layer can be seen between the interface of the 30% and 70% Percoll working solutions.
[0055] (5) Carefully remove the white cell layer (about 2-3 mL) using a pipette and place it in a new centrifuge tube. Add 10 mL of 1× HBSS (containing 2% v / v fetal bovine serum) and centrifuge repeatedly at 4°C and 2000 rpm to resuspend the cells. Wash the cells three times to obtain a single-cell suspension of brain tissue.
[0056] 7. Repeat steps 1 to 6 three times, i.e., perform four parallel tests.
[0057] Comparative Example 1
[0058] The brain tissue single cell suspension was prepared by a grinding and homogenization method, which differed from Example 1 in that papain was not used for enzymatic hydrolysis.
[0059] Comparative Example 2
[0060] The brain tissue single cell suspension was prepared by papain enzymatic hydrolysis. The difference from Example 1 was that the fresh neural tissue (rat / mouse brain tissue or spinal cord tissue) was directly transferred to the tissue dissociation tube in step 2 and neutralized without cutting.
[0061] Test Example 1
[0062] (1) The cell viability of the brain tissue single-cell suspensions obtained in Comparative Example 1, Comparative Example 2, and Example 1 was determined using the trypan blue exclusion method. The results are shown in FIG1 . FIG1 shows that the present invention utilizes a combination of mechanical and enzymatic methods to obtain a high cell viability of cells in the brain tissue single-cell suspension with good reproducibility.
[0063] (2) FITC-labeled Anti-mouse CD4, PE-labeled Anti-mouse CD25, APC-labeled Anti-mouse CD45 and other surface antibodies were added to the brain tissue single cell suspensions treated in Comparative Example 1, Comparative Example 2 and Example 1, respectively, and incubated and stained on ice in the dark for 30 minutes. Subsequently, 1×PBS was added to wash the cells, and the percentage of mononuclear cells in the brain tissue was detected by flow cytometry. The results are shown in Figure 2. As can be seen from Figure 2, the cell survival rate extracted by the technical solution of the present invention is high, and the separation process does not affect the cell activity and does not change its intracellular and extracellular marker proteins.
[0064] Based on the above content, it can be seen that the technical solution provided by the present invention is simple, quick and easy to operate, low-cost, and the obtained cells have high activity. Further cell culture, flow cytometric analysis, and protein and nucleic acid analysis can be performed. Combining these analysis techniques can achieve quantitative analysis of multiple parameters of single cells.
[0065] Although the above embodiment provides a detailed description of the present invention, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the scope of protection of the present invention.
Claims
1. A method for preparing a single-cell suspension of neural tissue, characterized in that: The steps include: (1) enzymatically hydrolyzing the neural tissue fragments with a hydrolytic enzyme solution, collecting the precipitate by centrifugation, and resuspending the fragments; the hydrolytic enzyme solution includes a trypsin solution or a papain solution, and the size of the fragments is less than 1 mm × 1 mm × 1 mm; the neural tissue includes brain tissue or spinal cord tissue; (2) filtering the resuspension obtained in step (1), centrifuging, and resuspending the precipitate in 30% Percoll working solution; (3) adding the resuspension obtained in step (2) to the top of 70% Percoll working solution, centrifuging, and collecting the white blood cell layer; (4) mixing the white blood cell layer obtained in step (3) with 1× Hank's balanced salt solution containing 2% v / v fetal bovine serum, centrifuging, collecting the precipitate and resuspending it to obtain the neural tissue single cell suspension; The 30% Percoll working solution is prepared by mixing 100% Percoll working solution and 1× Hank's balanced salt solution in a volume ratio of 3:7; The 70% Percoll working solution is prepared by mixing 100% Percoll working solution and 1× Hank's balanced salt solution in a volume ratio of 7:3; The 100% Percoll working solution is prepared by mixing the Percoll stock solution and 10×PBS in a volume ratio of 9:1; the 10×PBS is free of Ca 2+ and Mg 2+ , containing 0.5mmol / L EDTA.
2. The preparation method according to claim 1, characterized in that The enzymatic hydrolysis temperature is 55° C., the pH is 6.0, and the time is 30 min.
3. The preparation method according to claim 1, characterized in that The concentration of the enzyme in the hydrolase solution is 20 mg / mL.
4. The preparation method according to claim 1, characterized in that The centrifugal speed in step (1) is 2000 r / min and the time is 5 min.
5. The preparation method according to claim 1, characterized in that In step (2), filtration was performed using a cell sieve with a pore size of 70 μm.
6. The preparation method according to claim 1, characterized in that The centrifugation temperature in step (2) is 4° C., the rotation speed is 2000 r / min, and the time is 15 min.
7. The preparation method according to claim 1, characterized in that The volume ratio of the resuspension in step (3) to the 70% Percoll working solution is 10:
3.
8. The preparation method according to claim 1, characterized in that The centrifugation temperature in step (3) is 4° C., the rotation speed is 2000 r / min, the time is 15 min, the acceleration is set to 3, and the deceleration is set to 2.
9. The preparation method according to claim 1, characterized in that The centrifugation temperature in step (4) is 4° C., the rotation speed is 2000 r / min, and the time is 5 min.
10. The preparation method according to claim 1, characterized in that The resuspension in step (4) uses 1× Hank's balanced salt solution containing 2% v / v fetal bovine serum.
Citation Information
Patent Citations
Enzymatic hydrolysate suitable for enzymolysis of mouse brain tissue, cell separation method and application of enzymatic hydrolysate
CN114181926A
Preparation method of adult mouse brain tissue single-cell suspension and kit
CN116334175A
